Atea Pharmaceuticals Files 8-K on Financials
Ticker: AVIR · Form: 8-K · Filed: Jan 14, 2025 · CIK: 1593899
| Field | Detail |
|---|---|
| Company | Atea Pharmaceuticals, Inc. (AVIR) |
| Form Type | 8-K |
| Filed Date | Jan 14, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, sec-filing
TL;DR
Atea Pharma filed an 8-K for financial updates, standard procedure.
AI Summary
Atea Pharmaceuticals, Inc. filed an 8-K on January 14, 2025, reporting on events as of January 13, 2025. The filing pertains to the company's results of operations and financial condition, as well as financial statements and exhibits. No specific financial figures or significant events were detailed in the provided excerpt.
Why It Matters
This filing indicates Atea Pharmaceuticals is providing updates on its financial condition and operations to the SEC, which is standard for publicly traded companies.
Risk Assessment
Risk Level: low — The filing is a routine 8-K for financial reporting and does not indicate any immediate or significant risks.
Key Players & Entities
- Atea Pharmaceuticals, Inc. (company) — Registrant
- January 13, 2025 (date) — Date of earliest event reported
- January 14, 2025 (date) — Date of report
- 225 Summer Street Suite 2100 Boston, MA 02110 (location) — Principal executive offices address
FAQ
What specific financial information is being reported in this 8-K?
The provided excerpt states the 8-K covers 'Results of Operations and Financial Condition' and 'Financial Statements and Exhibits,' but does not detail specific figures.
What is the exact date of the earliest event reported in this filing?
The earliest event reported is dated January 13, 2025.
What is Atea Pharmaceuticals' principal executive office address?
The principal executive offices are located at 225 Summer Street Suite 2100, Boston, MA 02110.
What is the SEC file number for Atea Pharmaceuticals?
The SEC file number for Atea Pharmaceuticals is 001-39661.
What is the SIC code for Atea Pharmaceuticals?
The Standard Industrial Classification (SIC) code for Atea Pharmaceuticals is 2834, which corresponds to Pharmaceutical Preparations.
Filing Stats: 658 words · 3 min read · ~2 pages · Grade level 12.1 · Accepted 2025-01-13 18:54:26
Key Financial Figures
- $0.001 — nge on which registered Common Stock, $0.001 par value per share AVIR The Nasdaq
Filing Documents
- d924755d8k.htm (8-K) — 26KB
- d924755dex991.htm (EX-99.1) — 18KB
- g924755g0114012023422.jpg (GRAPHIC) — 3KB
- 0001193125-25-005424.txt ( ) — 174KB
- avir-20250113.xsd (EX-101.SCH) — 3KB
- avir-20250113_lab.xml (EX-101.LAB) — 18KB
- avir-20250113_pre.xml (EX-101.PRE) — 11KB
- d924755d8k_htm.xml (XML) — 4KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Press release dated January 13, 2025. 104 Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ATEA PHARMACEUTICALS, INC. Date: January 13, 2025 By: /s/ Andrea Corcoran Andrea Corcoran Chief Financial Officer and Executive Vice President, Legal and Secretary